SCHEMBL25663107

SCHEMBL25663107

c1ccc2nc(-c3ccc(N(c4ccc(-c5ncc6ccccc6n5)cc4)c4ccc(-c5ncnc6sc7ccccc7c56)cc4)cc3)ncc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 5/20 0.47
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CA P42336 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ LMNA P02545 3/20 0.34
▸ MAPT P10636 3/20 0.34
▸ RECQL P46063 2/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ ELANE P08246 1/20 0.33
▸ KDM4E B2RXH2 3/20 0.32
▸ CYP3A4 P08684 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ CYP2C9 P11712 2/20 0.32
▸ HPGD P15428 2/20 0.32
▸ TSHR P16473 2/20 0.32
▸ CYP2C19 P33261 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25663101 0.86 PIK3CA (0.48) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663175 0.84 CYP1A2 (0.48) CYP1A2LMNAMAPTRECQLSMN1; SMN2
SCHEMBL25663108 0.84 NPC1 (0.40) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663098 0.84 RAB9A (0.39) CYP1A2PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL25663099 0.82 NPC1 (0.39) CYP1A2PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL25663254 0.82 NPC1 (0.46) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663123 0.82 APP (0.50) LMNAMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL25663113 0.81 PIK3CD (0.33) CYP1A2PIK3CDPIK3CAPIK3CBMTOR
SCHEMBL25663119 0.80 TDO2 (0.40) PIK3CDPIK3CAPIK3CBMTORPIK3CG
SCHEMBL25663258 0.80 PIK3CA (0.36) PIK3CDPIK3CAPIK3CBMTORPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 CYP1A2 336/4885PIK3CD 4761/4885PIK3CA 4539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback